Workshops and Seminars
InfraLife aims at gathering stakeholders across sectors with the goal to spur new cross-sectorial collaborations. As a part of this work, InfraLife is organizing challenge-driven and technology-driven workshops, seminars and dialogues focusing around a certain biological/medical issue or a certain technology or method. The goal is to allow researchers from different sectors to meet, and to learn more about the potential of the research infrastructures as well as how the available techniques can help address specific research questions and be a part of the solution to the research challenge at hand.
At this page, you can see some of the activities that falls within the “Workshops and Seminars” category organized by InfraLife.

MAX IV user meeting 2025
Life Science collaboration between MAX IV, SciLifeLab and ESS
InfraLife hosted one session at the MAX IV user meeting in January 2025 including:
*Overview of the InfraLife project, introduction to SciLifeLab & ESS and panel discussion
*Integrated Structural Biology in Sweden, a collaborative and scientific example
*Spatial Imaging Methods, a collaborative scientific example with MAX IV and SciLifeLab
*Summary and future of the collaboration
Workshop
Infection Biology Across Scales
The European Molecular Biology Laboratory (EMBL), SciLifeLab, InfraLife and the Laboratory for Molecular Infection Medicine Sweden (MIMS) organised an in-person workshop on infection biology in February 2025 in Umeå. The workshop focused on exploring complementary platforms and capabilities of the organisations in light of the most important scientific challenges facing infection research. In the Session II: Imaging infection – from organisms to structure, Esko Oksanen, European Spallation Source (ESS), InfraLife project group and Lund University will give a talk.

Exchange dialogues
Pushing the development of research infrastructures
Through the initial phases of InfraLife it came to light that an unforeseen challenge was to raise awareness about the possibilities and contributions by research infrastructures to solve scientific problems between the infrastructure experts themselves. InfraLife developed an Exchange Dialogue meeting format with informal, short, online meetings where infrastructure representatives from MAX IV, SciLifeLab and ESS could get up to date with the latest possibilities for a specific topic and discuss future collaborations and synergies to push technology development. Exchange Dialogues were focused around the following themes; Fragment Screening (3), Imaging (4), Data Management (1), Environment (2) and Spatial Biolgy (3). Joint funding applications and keynote speaker invitations are some of the noteworthy aftereffects/consequences of these Exchange Dialogues.
Webinar
Industry case webinars: “How SciLifeLab and MAX IV collaborated with SARomics Biostructures in drug discovery projects”
In January 2024, InfraLife, together with partner organisations Lif and SwedenBIO, organised a joint webinar on how SciLifeLab and MAX IV industry use can contribute to drug discovery.

Webinar
Joint webinar with Lif: “How can SciLifeLab, MAX IV and ESS contribute to drug discovery and development?”
In November 2021, InfraLife, together with partner organization Lif, organized a joint webinar on how the SciLifeLab, MAX IV and ESS can contribute to drug discovery and development.
Workshop
Workshop on Antimicrobial resistance (AMR)
June 2021, The first InfraLife workshop gathered stakeholders in the field of antimicrobial resistance (AMR) for a joint discussion. The workshop included descriptions of the respective infrastructures and connected user case presentations with relevance to the AMR field as well as state of the art descriptions of the AMR filed from different perspectives. Whether it be surveillance and prevention strategies, material development or sampling techniques, cross-sectoral and cross-thematic collaboration is needed for the academic sector to feed scientific innovation into the innovation system, for the private sector to pursue product development, and for the health care systems to implement new findings and innovation in clinical practice. Specific aspects highlighted, where the research infrastructures could play a role, included creating clear entry ways for industry to use the infrastructures and increased expertise support when using the facilities.


